Log In
Print this Print this


Also known as: Glucagon for Injection, rGlucagon

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionRecombinant DNA glucagon
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsTreat severe hypoglycemia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today